Error loading player: No playable sources found

3585699

Implementation of virus filtration unit operations and evaluation of viral clearance under challenging process conditions

Date
August 25, 2021

Virus retentive filtration (VRF) has been a requirement in mammalian derived biologics purification for decades. As a part of a comprehensive viral safety platform, viral clearance using VRFs has been relied upon to remove both large and small viruses (>20nm) using a well-defined size-exclusion based mechanism. These VRF processes are validated for virus removal capability in viral clearance studies using both relevant and model viruses. While most studies using typical process parameters meet or exceed the viral clearance requirement set by the ICH Q5A, there are specific process conditions that impact viral clearance capability on many filters used in commercial manufacturing processes. These adverse process conditions include effects from process pause or low-pressure filtration and low pH (pH < 6) with high conductivity (>15mS/cm) feed streams. In an attempt to demonstrate these effects using the Sartorius Virosart HF filter, viral clearance studies were carried out that were designed to push virus filter validation to its limits. To do so, two monoclonal antibody feed streams were evaluated using several different pH and pressure conditions. After discussing the results of these viral clearance studies, a thorough evaluation of the use of gamma irradiated single use transfersets and filter assemblies such as the Sartorius MaxiCap MR system will be presented for commercial scale processing.

Speakers

Speaker Image for Abhijeet Shirke
Associate Director, Process Development, Teva Pharmaceuticals

Related Products

Thumbnail for Downstream Processing: Novel Harvest Technologies
Downstream Processing: Novel Harvest Technologies
DIVISION/COMMITTEE: [BIOT: Division of Biochemical Technology]
Thumbnail for Virus risk mitigation in viral vector and gene therapy cell culture media
Virus risk mitigation in viral vector and gene therapy cell culture media
Viral vector vaccine and gene therapies are a rapidly growing and evolving field. These products have a wide range of potential applications, such as treatment of cancer, genetic disorders and infectious disease…
Thumbnail for Characterization of upstream viral filters for virus retention of chemically defined media and feeds | Poster Board #3907
Characterization of upstream viral filters for virus retention of chemically defined media and feeds | Poster Board #3907
Viral contamination events in biologics facilities are rare, however, the impact to the facility and product supply can be devastating when they do occur…